Mostrando 10 resultados de: 23
Filtros aplicados
Publisher
American Society of Clinical Oncology(3)
Elsevier(2)
American Association for Cancer Research(1)
American Medical Association(1)
John Wiley & Sons, Ltd.(1)
Área temáticas
Enfermedades(20)
Farmacología y terapéutica(9)
Problemas sociales y servicios a grupos(3)
Cirugía y especialidades médicas afines(1)
Educación(1)
Área de conocimiento
Cáncer(15)
Farmacología(3)
Medicamento(2)
Medicina interna(2)
Cuidado de la salud(1)
Assessment of Sacituzumab Govitecan vs Treatment of Physician’s Choice Cohort by Agent in the Phase 3 ASCENT Study of Patients With Metastatic Triple‑Negative Breast Cancer
OtherAbstract: Background • Metastatic triple‑negative breast cancer (mTNBC) is a heterogenous disease with few trePalabras claves:Autores:Alejandra PérezFuentes:googleA phase I trial of scutellaria barbata (BZL101) for metastatic breast cancer.
OtherAbstract:Palabras claves:Autores:Alejandra PérezFuentes:googleDevelopment of a multigenerational digital lifestyle intervention for women cancer survivors and their families
OtherAbstract: Objectives This paper presents the results of a study developed to inform the design of a multigenerPalabras claves:Autores:Alejandra PérezFuentes:googleConducta ante las fracturas supracondileas en niños: revisión de 10 años en el Hospital Pérez de León
OtherAbstract: Se realizó un estudio retrospectivo de 56 niños con fracturas supracondíleas de húmero en el HospitaPalabras claves:Autores:Alejandra PérezFuentes:googleAbstract OT2-05-01: FLEX: 30K Full Transcriptome, Real-World Evidence Database for Early-Stage Breast Cancer, and Investigator-Initiated Protocols
OtherAbstract: FLEX: 30K Full Transcriptome, Real-World Evidence Database for Early-Stage Breast Cancer, and InvestPalabras claves:Autores:Alejandra PérezFuentes:googleAn Evaluation of the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2+ Metastatic Breast Cancer.
OtherAbstract: Background: Trastuzumab given concomitantly with paclitaxel is an established first-line metastaticPalabras claves:Autores:Alejandra PérezFuentes:googleAn Open‐Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First‐Line HER2‐Positive Metastatic Breast Cancer
OtherAbstract: Background. Recent data support the hypothesis that combining lapatinib and trastuzumab with taxanePalabras claves:Autores:Alejandra PérezFuentes:googleEverolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
OtherAbstract: Background The BOLERO-2 study previously demonstrated that adding everolimus (EVE) to exemestane (EXPalabras claves:Autores:Alejandra PérezFuentes:googleEXPLORING FEMALE CANCER SURVIVORS'IDEAS FOR A MULTI-GENERATIONAL DIGITAL LIFESTYLE INTERVENTION
OtherAbstract:Palabras claves:Autores:Alejandra PérezFuentes:googleEl desarrollo de las competencias transversales en la carrera de bioingeniería de la UNSJ: ¿alternativa ante la deserción universitaria? (Investigaciones)
ArticleAbstract: A raíz de la emergencia sanitaria ocasionada por la pandemia COVID-19 y la continuidad del curso enPalabras claves:Competencia Profesional, COMPETENCIAS TRANSVERSALES, DESERCION ESCOLAR, Enseñanza Superior, MEDIACIÓN PEDAGÓGICA, UNIVERSIDAD NACIONAL DE SAN JUAN, UNSJ, University dropoutAutores:Alejandra Pérez, Arnoldo Fernández, Cintia Páez, Paula Seminara, Sergio PérezFuentes:rraae